Subtotal $0.00
Dihexa is a small, chemically modified peptide derived from angiotensin IV, a fragment of the angiotensin hormone system that helps regulate blood pressure. It was developed by researchers at Washington State University and was designed to be more stable than angiotensin IV.
Research on Dihexa has been preclinical, meaning it has been studied in laboratory and animal models, including models related to memory. It has not been tested for safety or effectiveness in large human trials.
Current status: Not FDA-approved.
In practical terms, Dihexa has not gone through the FDA review that a drug must pass before it can be marketed for use in people. There is no FDA-approved product that contains it.
Because human data are lacking, its long-term effects in people are unknown.
Peptide Labs does not sell this compound. This page is general information, not medical advice. We do not supply Dihexa, and we do not point readers to anyone who does.
For personal medical questions, including questions about Dihexa, the right person to ask is a licensed healthcare provider.
See the full list of compound profiles in the Peptide Guide.
Shop Now
